There are an estimated 176 million chronic carriers of hepatitis B virus (HBV) world wide and strong epidiomological evidence linking the carrier state with development of hepatocellular carcinoma. Thus, it is of utmost importance to have in vitro systems available for studying viral replication and for elucidating the mechanism(s) by which HBV infected cells become malignantly transformed. Although it has been possible to obtain partial expression of viral functions by transfecting rodent cells with cloned HBV DNA, these cells do not support efficient viral replication nor do they become malignantly transformed. Nevertheless, cloned HBV DNA is capable of causing hepatitis in chimpanzees. The working hypothesis for the experiments proposed here is that the relatively weak promoters associated with HBV genes other than the gene coding for the surface antigen of the virus cannot overcome host and/or tissue specific restrictions imposed by rodent cells or cells of non-hepatic origin. Thus, to meet our long-term goal of establishing in vitro systems for studying HBV, we propose 1) to obtain increased expression of viral genes in mouse lines that already carry integrated HBV genes by a) treating them with compounds known to enhance expression of integrated viral genomes; b) exposing them to tumor promoters and subeffective doses of physical and chemical carcinogens and c) by """"""""superinfecting"""""""" them with additional recircularized HBV genomes or with new hybrid plasmids in which the viral genome is linked to strong promoters or enhancing sequences; 2) to develop hybrid plasmids designed to replicate episomally in simian cells or to give efficient expression of viral functions in cultured hepatocytes; 3) to create transgenic mice carrying HBV sequences by introducing recircularized HBV genomes or hybrid plasmids with HBV sequences linked to strong promoters into mouse embryo cells; 4) to develop methods of in situ hybridization suitable for use with biopsy material which will allow association of HBV gene expression with various clinical stages of chronic liver disease. These studies should elucidate at least some of the factors that regulate expression of HBV genes in cultured cells, in transgenic mice and in the liver of infected individuals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034818-03
Application #
3172653
Study Section
(SSS)
Project Start
1984-03-15
Project End
1987-08-31
Budget Start
1986-03-01
Budget End
1987-08-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Price, P M; Banerjee, R; Jeffrey, A M et al. (1992) The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine. Hepatology 16:8-12
Bauer, J; Lengyel, G; Thung, S N et al. (1991) Human fetal hepatocytes respond to inflammatory mediators and excrete bile. Hepatology 13:1131-41
Zhai, W R; Vajta, G; Acs, G et al. (1990) A nude mouse model for the in vivo production of hepatitis B virus. Gastroenterology 98:470-7
Banerjee, R; Price, P M; Sung, M W et al. (1990) Selective inhibition of hepatitis B virus and human immunodeficiency virus sequence-promoted gene expression by cotransfected poly(I):poly(C). Virology 179:410-5
Price, P M; Banerjee, R; Acs, G (1989) Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine. Proc Natl Acad Sci U S A 86:8541-4
Price, P M; Reichelderfer, C F; Johansson, B E et al. (1989) Complementation of recombinant baculoviruses by coinfection with wild-type virus facilitates production in insect larvae of antigenic proteins of hepatitis B virus and influenza virus. Proc Natl Acad Sci U S A 86:1453-6
Banerjee, R; Karpen, S; Siekevitz, M et al. (1989) Tumor necrosis factor-alpha induces a kappa B sequence-specific DNA-binding protein in human hepatoblastoma HepG2 cells. Hepatology 10:1008-13
Price, P M; Mohamad, A; Zelent, A et al. (1988) Translational selection in the expression of the hepatitis B virus envelope proteins. DNA 7:417-22
Sells, M A; Zelent, A Z; Shvartsman, M et al. (1988) Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 62:2836-44
Gerber, M A; Sells, M A; Chen, M L et al. (1988) Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro. Lab Invest 59:173-80

Showing the most recent 10 out of 18 publications